| 000 | 01644 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517035959.0 | ||
| 264 | 0 | _c20160607 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1873-4294 | ||
| 024 | 7 |
_a10.2174/1568026615666150622091407 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDocsa, Tibor | |
| 245 | 0 | 0 |
_aInsulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats. _h[electronic resource] |
| 260 |
_bCurrent topics in medicinal chemistry _c2015 |
||
| 300 |
_a2390-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
| 650 | 0 | 4 |
_aGlycogen _xmetabolism |
| 650 | 0 | 4 |
_aGlycogen Phosphorylase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMonosaccharides _xadministration & dosage |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSpiro Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aStreptozocin |
| 700 | 1 | _aMarics, Balázs | |
| 700 | 1 | _aNémeth, József | |
| 700 | 1 | _aHüse, Csaba | |
| 700 | 1 | _aSomsák, László | |
| 700 | 1 | _aGergely, Pál | |
| 700 | 1 | _aPeitl, Barna | |
| 773 | 0 |
_tCurrent topics in medicinal chemistry _gvol. 15 _gno. 23 _gp. 2390-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568026615666150622091407 _zAvailable from publisher's website |
| 999 |
_c25002098 _d25002098 |
||